Arcus Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcus Biosciences using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-28 | $-1.27 | $-1.31 | 3.05 % |
| Q2 | 2025-08-06 | $0.00 | $-1.16 | 100.1 % |
| Q1 | 2025-05-06 | $-1.14 | $-1.01 | -12.9 % |
| Q4 | 2025-02-25 | $-1.03 | $-1.20 | 14.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-28 | $26.00M | $20.33M | 27.9 % |
| Q2 | 2025-08-06 | $160.00M | $28.95M | 452.8 % |
| Q1 | 2025-05-06 | $28.00M | $38.61M | -27.5 % |
| Q4 | 2025-02-25 | $36.00M | $29.38M | 22.5 % |
Arcus Biosciences (RCUS) is scheduled to report earnings on February 24, 2026. The last reported earnings were for reported on October 28, 2025 for Q3.
The Actual EPS was $-1.27, which beat the estimate of $-1.31.
The Actual Revenue was $26M, which beat the estimate of $20.3M.
Browse earnings estimates, EPS, and revenue on all stocks.